Federal Register / Vol. 75, No. 248 / Tuesday, December 28, 2010 / Notices 81611 

1. Jan Malcolm Jones, Jr., and Leslie 

Ann Jones, both in Jacksonville, Florida; 

to retain outstanding voting shares of 

Florida Capital Group, Inc., and thereby 

indirectly retain outstanding voting 

shares of Florida Capital Bank, both in 

Jacksonville, Florida. 

Board of Governors of the Federal 

Reserve System, December 22, 2010. 

Robert deV. Frierson, 

Deputy Secretary of the Board. 

[FR Doc. 2010–32651 Filed 12–27–10; 8:45 am] 

BILLING CODE 6210–01–P 

FEDERAL RESERVE SYSTEM 

Formations of, Acquisitions by, and 

Mergers of Bank Holding Companies; 

Correction 

This notice corrects a notice (FR Doc. 

2010–32092) published on page 80501 

of the issue for Wednesday, December 

22, 2010. 

Under the Federal Reserve Bank of 

New York heading, the entry for Chuo 

Mitsui Trust Holding, Inc., Tokyo, 

Japan, is revised to read as follows: 

A. Federal Reserve Bank of New York 

(Ivan Hurwitz, Vice President) 33 

Liberty Street, New York, New York 

10045–0001: 

1. Chuo Mitsui Trust Holdings, Inc., 

Tokyo, Japan; to become a bank holding 

Company by acquiring The Sumitomo 

Trust and Banking Co., Ltd, Osaka, 

Japan, and thereby acquire Sumitomo 

Trust and Banking Co. (USA), Hoboken, 

New Jersey. 

In connection with this application, 

Applicant also has applied to acquire 

Nikko Americas Holding Co., Inc., 

Nikko Asset Management Americas, 

Inc., and Chuo Mitsui Investments, all 

in New York, New York, and thereby 

engage in investment advisory activities, 

pursuant to section 225.24(b)(6) of 

Regulation Y. 

Comments on this application must 

be received by January 18, 2011. 

Board of Governors of the Federal Reserve 

System, December 22, 2010. 

Robert deV. Frierson, 

Deputy Secretary of the Board. 

[FR Doc. 2010–32593 Filed 12–27–10; 8:45 am] 

BILLING CODE 6210–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Submission for OMB Review; 

Comment Request; National 

Evaluation of the Clinical and 

Translational Science Awards (CTSA) 

Initiative 

SUMMARY: Under the provisions of 

Section 3507(a)(1)(D) of the Paperwork 

Reduction Act of 1995, the National 

Center for Research Resources, the 

National Institutes of Health has 

submitted to the Office of Management 

and Budget (OMB) a request to review 

and approve the information collection 

listed below. This proposed information 

collection was previously published in 

the Federal Register on October 12, 

2010, pages 62543–62544, and allowed 

60-days for public comment. No 

comments were received. The purpose 

of this notice is to allow an additional 

30 days for public comment. The 

National Institutes of Health may not 

conduct or sponsor, and the respondent 

is not required to respond to, an 

information collection that has been 

extended, revised, or implemented on or 

after October 1, 1995, unless it displays 

a currently valid OMB control number. 

Proposed Collection: 

Title: The National Evaluation of the 

Clinical and Translational Science 

Awards (CTSA) Initiative. 

Type of Information Collection 

Request: New. 

Need and Use of Information 

Collection: The CTSA Initiative is 

directed at transforming the way 

biomedical research is conducted 

nationwide by reducing the time it takes 

for basic science or laboratory 

discoveries to become treatments for 

patients, and for those treatments in 

turn to be incorporated and 

disseminated throughout community 

practice. The primary purpose of this 

data collection is to provide information 

about the process and early outcomes 

associated with 46 awardees 

participating in the first four cohorts of 

CTSA awards, in order to fulfill the 

congressional expectations for external 

program evaluation. NIH will use the 

results to understand the extent to 

which the CTSA Initiative is bringing 

about transformational changes in 

clinical and translational science among 

academic medical centers and their 

research partners, increasing the 

efficiency of the research process, and 

enhancing the capacity of the field to 

conduct clinical and translational 

research. All information collected will 

be used to provide analytical and policy 

support to NCRR, assisting NIH in 

making decisions about current CTSA 

programming, future funding, and other 

initiatives to improve clinical and 

translational science. It may also 

provide information for NIH’s 

Government Performance and Results 

Act (GPRA) report. 

Frequency of Response: Biennial. 

Affected Public: Individuals. 

Type of Respondents: Scientific 

researchers. The annual reporting 

burden is as follows: 

Estimated Number of Respondents: 

3,563; 

Estimated Number of Responses per 

Respondent: 1; 

Average Burden Hours Per Response: 

0.13; 

Estimated Total Annual Burden 

Hours Requested: 451.5. The annualized 

cost to respondents is estimated at 

$14,056. There are no capital or start-up 

costs, and no maintenance or service 

cost components to report. 

Respondent type 

Estimated 

number of 

respondents 

Estimated 

number of 

hours per 

respondent 

type 

Frequency of 

response 

Estimated 

total annual 

burden hours 

requested 

Users survey .................................................................................................... 500 .25 .5 62.5

Nonusers survey .............................................................................................. 500 .08 .5 20.0 

Trainees/scholars survey ................................................................................. 1,213 .33 .5 200.0 

Mentors survey ................................................................................................ 1,350 .25 .5 169.0 

Total .......................................................................................................... ........................ ........................ ........................ 451.5 

Request for Comments: Written 

comments and/or suggestions from the 

public and affected agencies should 

address one or more of the following 

points: (1) Evaluate whether the 

proposed collection of information is 

necessary for the proper performance of 

the function of the agency, including 

whether the information will have 

practical utility; (2) Evaluate the 

accuracy of the agency’s estimate of the 

burden of the proposed collection of 


emcdonald on DSK2BSOYB1PROD with NOTICES